Analyze Diet
Journal of the American Veterinary Medical Association2005; 227(6); 954-959; doi: 10.2460/javma.2005.227.954

Efficacy of Saccharomyces boulardii for treatment of horses with acute enterocolitis.

Abstract: To evaluate the viability of Saccharomyces boulardii after PO administration in clinically normal horses and its efficacy as a treatment for horses with acute enterocolitis. Methods: Prospective study. Methods: 5 clinically normal horses and 14 horses with acute enterocolitis. Methods: Feces were collected from 5 clinically normal horses and submitted for microbial culture for 2 days prior to administration of a lyophilized form of S. boulardii (25 or 50 g, PO, q 12 h) for 10 days. Feces were collected for microbial culture 5 and 10 days after treament initiation and 10 days after treatment was discontinued. Fourteen horses with acute enterocolitis were randomly allocated to receive a placebo or S. boulardii (25 g), PO, every 12 hours for 14 days. Results: S. boulardii was not detected in feces of clinically normal horses. After administration, yeast survived within the gastroinestinal tract but did not permanently colonize it. In horses with acute enterocolitis, the severity and duration of gastrointestinal tract disease during hospitalization were significantly decreased in horses receiving S. boulardii, compared with horses receiving the placebo. Conclusions: Administration of S. boulardii may help decrease the severity and duration of clinical signs in horses with acute enterocolitis.
Publication Date: 2005-09-30 PubMed ID: 16190596DOI: 10.2460/javma.2005.227.954Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Journal Article
  • Randomized Controlled Trial
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the use of Saccharomyces boulardii, a type of yeast, in the treatment of acute enterocolitis (gastrointestinal disease) in horses, showing positive effects in reducing disease severity and duration.

Objective of the research

  • The aim of this study was to investigate the viability and efficacy of Saccharomyces boulardii, a yeast, when orally administered to horses. The primary focus was on its use as a potential treatment method for horses suffering from acute enterocolitis, a severe inflammation of the intestines.

Methodology

  • This prospective study involved 5 clinically normal horses and 14 horses with acute enterocolitis.
  • Fecal samples were collected from the normal horses 2 days prior to the treatment with a lyophilized (freeze-dried) form of S. boulardii, and then again at 5 and 10 days into the treatment, and finally, 10 days after the treatment was discontinued. This helped in understanding how the yeast colonies evolved in the horses’ digestive systems over time.
  • The 14 horses suffering from acute enterocolitis were randomly selected to receive either a placebo or S. boulardii treatment. The treatment regimen lasted for 14 days.

Results

  • S. boulardii was not detected in the feces of clinically normal horses prior to beginning the treatment.
  • Despite not colonizing the intestinal tract permanently, the yeast survived within the gastrointestinal tracts of the horses after administration, suggesting it may interact with the surrounding microbiota or influence the gut environment without persisting long term.
  • The study observed significant improvements in the horses with acute enterocolitis that received the S. boulardii treatment in comparison to those who received the placebo. These horses exhibited a decrease in both the severity and duration of their gastrointestinal tract disease during their hospitalization.

Conclusions

  • The research concluded that the administration of S. boulardii could help alleviate clinical symptoms, decreasing the severity and duration of acute enterocolitis in horses. However, more research may be necessary to fully understand the workings of this treatment, its long-term effects, and potential side effects considering that S. boulardii did not permanently colonize the intestinal tract.

Cite This Article

APA
Desrochers AM, Dolente BA, Roy MF, Boston R, Carlisle S. (2005). Efficacy of Saccharomyces boulardii for treatment of horses with acute enterocolitis. J Am Vet Med Assoc, 227(6), 954-959. https://doi.org/10.2460/javma.2005.227.954

Publication

ISSN: 0003-1488
NlmUniqueID: 7503067
Country: United States
Language: English
Volume: 227
Issue: 6
Pages: 954-959

Researcher Affiliations

Desrochers, Anne M
  • Department of Clinical Studies, New Bolton Center campus, University of Pennsylvania, Kennett Square PA 19348, USA.
Dolente, Brett A
    Roy, Marie-France
      Boston, Raymond
        Carlisle, Sharon

          MeSH Terms

          • Acute Disease
          • Animals
          • Enterocolitis / microbiology
          • Enterocolitis / therapy
          • Enterocolitis / veterinary
          • Feces / microbiology
          • Female
          • Horse Diseases / microbiology
          • Horse Diseases / therapy
          • Horses
          • Male
          • Probiotics / therapeutic use
          • Prospective Studies
          • Saccharomyces / physiology
          • Severity of Illness Index
          • Time Factors
          • Treatment Outcome

          Citations

          This article has been cited 14 times.
          1. Hain-Saunders NMR, Knight DR, Bruce M, Riley TV. Clostridioides difficile infection and One Health: an equine perspective.. Environ Microbiol 2022 Mar;24(3):985-997.
            doi: 10.1111/1462-2920.15898pubmed: 35001483google scholar: lookup
          2. Goodman-Davis R, Figurska M, Cywinska A. Gut Microbiota Manipulation in Foals-Naturopathic Diarrhea Management, or Unsubstantiated Folly?. Pathogens 2021 Sep 4;10(9).
            doi: 10.3390/pathogens10091137pubmed: 34578169google scholar: lookup
          3. Kauter A, Epping L, Semmler T, Antao EM, Kannapin D, Stoeckle SD, Gehlen H, Lübke-Becker A, Günther S, Wieler LH, Walther B. The gut microbiome of horses: current research on equine enteral microbiota and future perspectives.. Anim Microbiome 2019 Nov 13;1(1):14.
            doi: 10.1186/s42523-019-0013-3pubmed: 33499951google scholar: lookup
          4. Walshe N, Mulcahy G, Hodgkinson J, Peachey L. No Worm Is an Island; The Influence of Commensal Gut Microbiota on Cyathostomin Infections.. Animals (Basel) 2020 Dec 5;10(12).
            doi: 10.3390/ani10122309pubmed: 33291496google scholar: lookup
          5. Lawson AL, Sherlock CE, Ireland JL, Mair TS. Equine nutrition in the post-operative colic: Survey of Diplomates of the American Colleges of Veterinary Internal Medicine and Veterinary Surgeons, and European Colleges of Equine Internal Medicine and Veterinary Surgeons.. Equine Vet J 2021 Sep;53(5):1015-1024.
            doi: 10.1111/evj.13381pubmed: 33174212google scholar: lookup
          6. Mallicote M, House AM, Sanchez LC. A review of foal diarrhoea from birth to weaning.. Equine Vet Educ 2012 Apr;24(4):206-214.
          7. Stewart AS, Pratt-Phillips S, Gonzalez LM. Alterations in Intestinal Permeability: The Role of the "Leaky Gut" in Health and Disease.. J Equine Vet Sci 2017 May;52:10-22.
            doi: 10.1016/j.jevs.2017.02.009pubmed: 31000910google scholar: lookup
          8. Shaw SD, Stämpfli H. Diagnosis and Treatment of Undifferentiated and Infectious Acute Diarrhea in the Adult Horse.. Vet Clin North Am Equine Pract 2018 Apr;34(1):39-53.
            doi: 10.1016/j.cveq.2017.11.002pubmed: 29426709google scholar: lookup
          9. Schoster A, Staempfli HR, Guardabassi LG, Jalali M, Weese JS. Comparison of the fecal bacterial microbiota of healthy and diarrheic foals at two and four weeks of life.. BMC Vet Res 2017 May 30;13(1):144.
            doi: 10.1186/s12917-017-1064-xpubmed: 28558788google scholar: lookup
          10. Harlow BE, Lawrence LM, Harris PA, Aiken GE, Flythe MD. Exogenous lactobacilli mitigate microbial changes associated with grain fermentation (corn, oats, and wheat) by equine fecal microflora ex vivo.. PLoS One 2017;12(3):e0174059.
            doi: 10.1371/journal.pone.0174059pubmed: 28358885google scholar: lookup
          11. Schoster A, Staempfli HR, Abrahams M, Jalali M, Weese JS, Guardabassi L. Effect of a probiotic on prevention of diarrhea and Clostridium difficile and Clostridium perfringens shedding in foals.. J Vet Intern Med 2015 May-Jun;29(3):925-31.
            doi: 10.1111/jvim.12584pubmed: 25903509google scholar: lookup
          12. Ishizaka S, Matsuda A, Amagai Y, Oida K, Jang H, Ueda Y, Takai M, Tanaka A, Matsuda H. Oral administration of fermented probiotics improves the condition of feces in adult horses.. J Equine Sci 2014;25(4):65-72.
            doi: 10.1294/jes.25.65pubmed: 25558179google scholar: lookup
          13. Schoster A, Weese JS, Guardabassi L. Probiotic use in horses - what is the evidence for their clinical efficacy?. J Vet Intern Med 2014 Nov-Dec;28(6):1640-52.
            doi: 10.1111/jvim.12451pubmed: 25231539google scholar: lookup
          14. Costa MC, Arroyo LG, Allen-Vercoe E, Stämpfli HR, Kim PT, Sturgeon A, Weese JS. Comparison of the fecal microbiota of healthy horses and horses with colitis by high throughput sequencing of the V3-V5 region of the 16S rRNA gene.. PLoS One 2012;7(7):e41484.
            doi: 10.1371/journal.pone.0041484pubmed: 22859989google scholar: lookup